https://investor.ironwoodpharma.com/press-releases/press-release-details/2015/Astellas-and-Ironwood-Report-Positive-Top-Line-Data-from-Phase-III-IBS-C-Trial-Conducted-in-Japan/default.aspx
Ironwood Pharmaceuticals is a leading gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI patients.
- November 30, 2015